Geode Capital Management, LLC Prelude Therapeutics Inc Transaction History

Geode Capital Management, LLC

  • $1.24 Trillion
  • Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 404,955 shares of PRLD stock, worth $356,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
404,955
Previous 402,336 0.65%
Holding current value
$356,360
Previous $510,000 39.02%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$0.64 - $1.39 $1,676 - $3,640
2,619 Added 0.65%
404,955 $311,000
Q4 2024

Feb 12, 2025
BUY
$0.8 - $2.04 $8,496 - $21,664
10,620 Added 2.71%
402,336 $510,000
Q3 2024

Nov 12, 2024
BUY
$2.07 - $6.37 $61,613 - $189,603
29,765 Added 8.22%
391,716 $810,000
Q2 2024

Aug 09, 2024
BUY
$3.32 - $5.63 $1,059 - $1,795
319 Added 0.09%
361,951 $1.38 Million
Q1 2024

May 13, 2024
BUY
$2.68 - $4.84 $32,870 - $59,362
12,265 Added 3.51%
361,632 $1.71 Million
Q4 2023

Feb 13, 2024
BUY
$1.69 - $4.37 $30,871 - $79,826
18,267 Added 5.52%
349,367 $1.49 Million
Q3 2023

Nov 13, 2023
BUY
$2.74 - $4.79 $243,328 - $425,380
88,806 Added 36.65%
331,100 $1.02 Million
Q2 2023

Aug 11, 2023
BUY
$4.45 - $8.12 $428,935 - $782,686
96,390 Added 66.06%
242,294 $1.09 Million
Q1 2023

May 15, 2023
BUY
$4.58 - $7.34 $5,619 - $9,006
1,227 Added 0.85%
145,904 $831,000
Q4 2022

Feb 13, 2023
SELL
$4.61 - $8.5 $38,788 - $71,519
-8,414 Reduced 5.5%
144,677 $873,000
Q3 2022

Nov 14, 2022
BUY
$5.0 - $8.82 $87,250 - $153,909
17,450 Added 12.86%
153,091 $1.01 Million
Q2 2022

Aug 12, 2022
SELL
$4.0 - $7.55 $287,740 - $543,109
-71,935 Reduced 34.65%
135,641 $708,000
Q1 2022

May 13, 2022
SELL
$6.9 - $13.22 $34,914 - $66,893
-5,060 Reduced 2.38%
207,576 $1.43 Million
Q4 2021

Feb 11, 2022
SELL
$11.89 - $31.74 $434,413 - $1.16 Million
-36,536 Reduced 14.66%
212,636 $2.65 Million
Q3 2021

Nov 12, 2021
BUY
$25.78 - $38.65 $668,217 - $1 Million
25,920 Added 11.61%
249,172 $7.79 Million
Q2 2021

Aug 13, 2021
BUY
$28.63 - $44.3 $688,866 - $1.07 Million
24,061 Added 12.08%
223,252 $6.39 Million
Q1 2021

May 12, 2021
BUY
$39.27 - $91.68 $296,999 - $693,375
7,563 Added 3.95%
199,191 $8.63 Million
Q4 2020

Feb 12, 2021
BUY
$28.81 - $88.94 $5.52 Million - $17 Million
191,628 New
191,628 $13.7 Million

Others Institutions Holding PRLD

# of Institutions
57
Shares Held
28.3M
Call Options Held
23.9K
Put Options Held
0
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $32M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email